Search Results - "Amos, Keith D."

Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression by HWANG, Rosa F, MOORE, Todd, ARUMUGAM, Thiruvengadam, RAMACHANDRAN, Vijaya, AMOS, Keith D, RIVERA, Armando, BAOAN JI, EVANS, Douglas B, LOGSDON, Craig D

“…Pancreatic adenocarcinoma is characterized by a dense background of tumor associated stroma originating from abundant pancreatic stellate cells. The aim of…”
Get full text

Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples by Elloumi, Fathi, Hu, Zhiyuan, Li, Yan, Parker, Joel S, Gulley, Margaret L, Amos, Keith D, Troester, Melissa A

“…Genomic tests are available to predict breast cancer recurrence and to guide clinical decision making. These predictors provide recurrence risk scores along…”
Get full text

Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma by Baker, Justin J., M.D, Meyers, Michael O., M.D, Frank, Jill, M.S, Amos, Keith D., M.D, Stitzenberg, Karyn B., M.D, Ollila, David W., M.D

“…Abstract Background Follow-up of patients with sentinel lymph node–positive stage III melanoma uses history, physical exam, and cross-sectional imaging. The…”
Get full text

Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ by Casbas-Hernandez, Patricia, D'Arcy, Monica, Roman-Perez, Erick, Brauer, Heather Ann, McNaughton, Kirk, Miller, Samantha M, Chhetri, Raghav K, Oldenburg, Amy L, Fleming, Jodie M, Amos, Keith D, Makowski, Liza, Troester, Melissa A

“…Basal-like and luminal breast cancers have distinct stromal-epithelial interactions, which play a role in progression to invasive cancer. However, little is…”
Get full text

Who teaches basic procedural skills: Student experience versus faculty opinion by Carr, Jacquelyn, MD, Deal, Allison M., MS, Dehmer, Jeffrey, MD, Amos, Keith D., MD, FACS, Farrell, Timothy M., MD, FACS, Meyer, Anthony A., MD, PhD, FACS, Meyers, Michael O., MD, FACS

“…Abstract Introduction Learning procedural skills as a medical student has evolved, as task trainers and simulators are now ubiquitous. It is yet unclear…”
Get full text

Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials by Amos, Keith D., Anders, Carey K., Adamo, Barbara

“…Triple-negative breast cancer (TNBC) is an aggressive malignancy with a poor prognosis despite the high rates of response to chemotherapy. This scenario…”
Get full text

Relative value unit impact of complex skin closures to academic surgical melanoma practices by Khandelwal, Cathleen M. Sybert, M.D, Meyers, Michael O., M.D., F.A.C.S, Yeh, Jen Jen, M.D., F.A.C.S, Amos, Keith D., M.D., F.A.C.S, Frank, Jill S., M.S, Long, Patricia, R.N., M.S.N, Ollila, David W., M.D., F.A.C.S

“…Abstract Background Melanoma excisions frequently are associated with significant soft-tissue defects, creating the need for complex closures. These closures…”
Get full text

Magnetic Resonance Imaging as a Predictor of Pathologic Response in Patients Treated With Neoadjuvant Systemic Treatment for Operable Breast Cancer: Translational Breast Cancer Research Consortium Trial 017 by DE LOS SANTOS, Jennifer F, CANTOR, Alan, MESZOELY, Ingrid M, NANDA, Rita, HWANG, E. Shelley, AMOS, Keith D, FORERO, Andres, GOLSHAN, Mehra, HORTON, Janet K, HUDIS, Clifford A, HYLTON, Nola M, MCGUIRE, Kandace, MERIC-BERNSTAM, Funda

“…Increased pathologic complete response (pCR) rates observed with neoadjuvant chemotherapy (NCT) for some subsets of patients with invasive breast cancer have…”
Get full text

Metastatic Melanoma Cells in the Sentinel Node Cannot Be Ignored by Ollila, David W., MD, FACS, Ashburn, Jean H., MD, Amos, Keith D., MD, FACS, Yeh, Jen Jen, MD, FACS, Frank, Jill S., MS, Deal, Allison M., MS, Long, Patricia, RN, MSN, Thomas, Nancy D., MD, PhD, Meyers, Michael O., MD, FACS

“…Background How to best risk-stratify patients with metastatic melanoma in the sentinel node (SN) is controversial. Not all node-positive disease is equivalent…”
Get full text

Age and Breslow Depth Are Associated with a Positive Sentinel Lymph Node in Patients with Cutaneous Melanocytic Tumors of Uncertain Malignant Potential by Meyers, Michael O., MD, FACS, Yeh, Jen Jen, MD, FACS, Deal, Allison M., MS, Byerly, Faera L., MD, Woosley, John T., MD, PhD, Frank, Jill, MS, Long, Patricia K., FNP, Amos, Keith D., MD, FACS, Ollila, David W., MD, FACS

“…Background Atypical melanocytic neoplasms present a therapeutic dilemma. Current consensus is to perform a sentinel lymph node (SLN) biopsy as part of…”
Get full text

Competence and confidence with basic procedural skills: the experience and opinions of fourth-year medical students at a single institution by Dehmer, Jeffrey J, Amos, Keith D, Farrell, Timothy M, Meyer, Anthony A, Newton, Warren P, Meyers, Michael O

“…Data indicate that students are unprepared to perform basic medical procedures on graduation. The authors' aim was to characterize graduating students'…”
Get full text

Transition to Surgical Residency: A Multi-Institutional Study of Perceived Intern Preparedness and the Effect of a Formal Residency Preparatory Course in the Fourth Year of Medical School by Minter, Rebecca M, Amos, Keith D, Bentz, Michael L, Blair, Patrice Gabler, Brandt, Christopher, D’Cunha, Jonathan, Davis, Elisabeth, Delman, Keith A, Deutsch, Ellen S, Divino, Celia, Kingsley, Darra, Klingensmith, Mary, Meterissian, Sarkis, Sachdeva, Ajit K, Terhune, Kyla, Termuhlen, Paula M, Mullan, Patricia B

“…PURPOSETo evaluate interns’ perceived preparedness for defined surgical residency responsibilities and to determine whether fourth-year medical school (M4)…”
Get full text

A Pilot Study of a Home-Based Motivational Exercise Program for African American Breast Cancer Survivors: Clinical and Quality-of-Life Outcomes by Spector, Denise, Deal, Allison M., Amos, Keith D., Yang, Hojin, Battaglini, Claudio L.

“…Introduction. African American breast cancer survivors engage in less physical activity compared with their Caucasian counterparts. There is a need for…”
Get full text

Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients by Román-Pérez, Erick, Casbas-Hernández, Patricia, Pirone, Jason R, Rein, Jessica, Carey, Lisa A, Lubet, Ronald A, Mani, Sendurai A, Amos, Keith D, Troester, Melissa A

“…A gene expression signature indicative of activated wound responses is common to more than 90% of non-neoplastic tissues adjacent to breast cancer, but these…”
Get full text

Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer by Meyers, Michael O., Klauber-DeMore, Nancy, Ollila, David W., Amos, Keith D., Moore, Dominic T., Drobish, Amy A., Burrows, Emily M., Dees, E. Claire, Carey, Lisa A.

“…Background Gene expression studies have identified distinct breast cancer subtypes, including luminal A, luminal B, Her2-enriched, and Basal-like, which differ…”
Get full text

Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer by Reeder-Hayes, Katherine E., Bainbridge, John, Meyer, Anne Marie, Amos, Keith D., Weiner, Bryan J., Godley, Paul A., Carpenter, William R.

“…To evaluate differences in use of sentinel lymph node biopsy (SLNB) by age and race in Medicare recipients with early-stage breast cancer, we examined…”
Get full text

Method of Detection of Initial Recurrence of Stage II/III Cutaneous Melanoma: Analysis of the Utility of Follow-Up Staging by Meyers, Michael O., Yeh, Jen Jen, Frank, Jill, Long, Patricia, Deal, Allison M., Amos, Keith D., Ollila, David W.

“…Background The follow-up of patients with cutaneous melanoma is controversial. Current recommendations suggest routine history and physical examination every 3…”
Get full text

The Role of Organizational Affiliations and Research Networks in the Diffusion of Breast Cancer Treatment Innovation by Carpenter, William R., Reeder-Hayes, Katherine, Bainbridge, John, Meyer, Anne-Marie, Amos, Keith D., Weiner, Bryan J., Godley, Paul A.

“…Introduction: The National Institutes of Health (NIH) sees provider-based research networks and other organizational linkages between academic researchers and…”
Get full text

Surgical Patterns of Care in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast Magnetic Resonance Imaging: Results of a Secondary Analysis of TBCRC 017 by McGuire, Kandace P., Hwang, E. Shelley, Cantor, Alan, Golshan, Mehra, Meric-Bernstam, Funda, Horton, Janet K., Nanda, Rita, Amos, Keith D., Forero, Andres, Hudis, Cliff A., Meszoely, Ingrid, De Los Santos, Jennifer F.

“…Background Neoadjuvant chemotherapy (NCT) downstages advanced primary tumors, with magnetic resonance imaging (MRI) being the most sensitive imaging predictor…”
Get full text

Responding to a Community's Concern: A Comparison of Breast Cancer Characteristics and Initial Treatment in Three Selected North Carolina Counties by Vines, Anissa I, Carpenter, William R, Chen, Ronald C, Cherry, Michele W, Long, Debra G, Amos, Keith D, Godley, Paul A

“…A 2007 national report identified North Carolina's Edgecombe County as having among the highest breast cancer incidence and mortality rates nationally,…”
Get full text